tiprankstipranks
GlaxoSmithKline Pharmaceuticals Limited (IN:GLAXO)
:GLAXO
India Market
GLAXO
GlaxoSmithKline Pharmaceuticals Limited
RESEARCH TOOLSreports

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Income Statement

Compare
1 Followers

GlaxoSmithKline Pharmaceuticals Limited Income Statement

Last quarter (Q1 2024), GlaxoSmithKline Pharmaceuticals Limited's total revenue was ₹8.15B, an increase of 6.96% from the same quarter last year. In Q1, GlaxoSmithKline Pharmaceuticals Limited's net income was ₹1.82B. See GlaxoSmithKline Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
₹ 34.54B₹ 32.52B₹ 32.78B₹ 31.99B₹ 32.24B
Gross Profit
₹ 20.34B₹ 19.67B₹ 18.28B₹ 18.04B₹ 18.27B
Operating Expenses
₹ 7.38B₹ 12.28B₹ 11.30B₹ 11.53B₹ 13.48B
Depreciation and Amortization
₹ 695.36M₹ 656.23M₹ 680.42M₹ 784.61M₹ 825.34M
EBITDA
₹ 8.87B₹ 9.03B₹ 8.49B₹ 5.36B₹ 3.92B
Operating Income
₹ 13.60B₹ 8.39B₹ 7.69B₹ 7.61B₹ 5.43B
Other Income/Expenses
₹ -5.44B₹ -4.03B₹ -3.79B₹ -5.02B₹ -1.74B
Pretax Income
₹ 8.16B₹ 8.36B₹ 7.79B₹ 5.50B₹ 3.06B
Net Income
₹ 5.90B₹ 6.11B₹ 3.81B₹ 3.58B₹ 932.05M
Per Share Metrics
₹ ―₹ ―₹ ―₹ ―₹ ―
Basic EPS
₹ 34.83₹ 36.05₹ 22.48₹ 21.14₹ 5.50
Diluted EPS
₹ 34.83₹ 36.05₹ 22.48₹ 21.14₹ 5.50
Weighted Average Shares Outstanding
169.41M 169.41M 169.41M 169.41M 169.41M
Weighted Average Shares Outstanding (Diluted)
169.41M 169.41M 169.41M 169.41M 169.41M
Currency in INR

GlaxoSmithKline Pharmaceuticals Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis